Surmodics to Participate in Upcoming Investor Conferences in March and April

Rhea-AI Summary

Surmodics, Inc. (SRDX) will participate in investor conferences, including the 34th Annual Oppenheimer Healthcare Conference and the 23rd Annual Needham Healthcare Conference. Management will present and participate in fireside chats at these events, offering insights into the company's medical device and in vitro diagnostic technologies.

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the following upcoming investor conferences:

The 34th Annual Oppenheimer Healthcare Conference, which is being held virtually from March 12-13, 2024.

• Management will present on Wednesday, March 13, at 2:00 p.m. Eastern Time.

The 23rd Annual Needham Healthcare Conference, which is being held virtually from April 8-11, 2024.

• Management will participate in a fireside chat on Tuesday, April 9, at 3:00 p.m. Eastern Time.

To access live webcasts of the presentations, go to “Events & Presentations” under the “Investors” section of the Company’s website at https://surmodics.gcs-web.com/events-and-presentations, and click on the webcast icon under “Upcoming Events.” Replays of the webcasts will be archived on the website for the following 90 days.

About Surmodics, Inc.

Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities. The Company’s mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227712577/en/

Surmodics Investor Inquiries:

Jack Powell, Investor Relations

ir@surmodics.com

Source: Surmodics, Inc.

FAQ

When is Surmodics, Inc. participating in the 34th Annual Oppenheimer Healthcare Conference?

Surmodics, Inc. will present at the 34th Annual Oppenheimer Healthcare Conference on Wednesday, March 13, 2024, at 2:00 p.m. Eastern Time.

What is the 23rd Annual Needham Healthcare Conference schedule for Surmodics, Inc.?

Surmodics, Inc. will participate in a fireside chat at the 23rd Annual Needham Healthcare Conference on Tuesday, April 9, 2024, at 3:00 p.m. Eastern Time.

Where can investors access live webcasts of Surmodics, Inc.'s presentations?

Investors can access live webcasts of Surmodics, Inc.'s presentations by visiting the 'Events & Presentations' section under the 'Investors' tab on the Company's website at https://surmodics.gcs-web.com/events-and-presentations.

How long will the replays of the webcasts be available on Surmodics, Inc.'s website?

Replays of the webcasts will be archived on Surmodics, Inc.'s website for the following 90 days after the live presentations.